Home >Participating Cliinical Centers >The Cleveland Clinic Foundation

Participating Clinical Centers

The Cleveland Clinic Foundation

Contact Information:

Gary Hoffman, M.D., M.S.
Professor of Medicine
Harold C. Schott Chair of Rheumatic and Immunologic Diseases
Director
Center for Vasculitis Care and Research
Lerner College of Medicine
Cleveland Clinic Foundation
9500 Euclid Ave A50
Cleveland, OH 44195
E-mail:hoffmag@ccf.org

Carol A. Langford, M.D., M.H.S.
Director, Center for Vasculitis Care and Research
Department of Rheumatic and Immunologic Diseases

Cleveland Clinic Foundation
Lerner College of Medicine
Cleveland Clinic Foundation A50
9500 Euclid Ave
Cleveland, OH 44195
E-mail: LANGFOC@ccf.org
Tel: 216-445-6056
Fax: 216-445-7569

Katherine Tuthill
Study Coordinator
E-mail: tuthillk@ccf.org
Phone: 216-444-5257

About Us:

The Cleveland Clinic Vasculitis Center has an international reputation for the care of patients with vasculitis and research into these diseases. The Cleveland Clinic Vasculitis Center has led or participated in all of the major U.S.-based multicentered clinical trials in vasculitis in the past ten years. Dr. Carol Langford is the Director of the Center for Vasculitis Care and Research at the Cleveland Clinic.

Current Studies:

5502: Longitudinal Protocol for Giant Cell Arteritis

5503: Longitudinal Protocol for Takayasu's Arteritis

5504: Longitudinal Protocol for Polyarteritis Nodosa

5505: Longitudinal Protocol for Wegener's Granulomatosis and Microscopic Polyangiitis

5506: Longitudinal Protocol for Churg-Strauss Syndrome

5515: VCRC Imaging Protocol for Magnetic Resonance and Positron Emission Tomography in Large-Vessel Vasculitis (Takayasu's Arteritis): Development as Clinical Trial Outcome Measures

5510: VCRC Genetic Repository One-Time DNA Study

5522: VCRC Multi-Center, Open-Label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener’s Granulomatosis (WG)

5523: Concurrent Pilot Studies in Giant Cell Arteritis and Takayasu’s Arteritis to Examine the Safety, Efficacy, and Immunologic Effects of Abatacept (CTLA4-Ig) in Large Vessel Vasculitis (AGATA)

Useful Links:

The Cleveland Clinic Center for Vasculitis